Latham & Watkins represented Amgen in the offerings. Amgen Inc., one of the world’s leading biotechnology companies, priced on February 17, 2022, a senior unsecured notes […]
Amgen’s $4 Billion Senior Unsecured Notes Offerings
Zynga’s Acquisition of NanoTribe
Latham & Watkins advised Zynga on the deal. Zynga Inc. (Nasdaq: ZNGA), a global leader in interactive entertainment, executed its acquisition of NanoTribe, an independent mobile […]
CooperCompanies’ Acquisition of Cook Medical’s Reproductive Health Business
Latham & Watkins represented CooperCompanies in the transaction. CooperCompanies has announced it has signed a binding letter of intent to acquire Cook Medical’s Reproductive Health business, a manufacturer […]
Royal Philips’ Acquisition of Vesper Medial
Latham & Watkins represented Vesper Medical in the transaction. Royal Philips (NYSE: PHG; AEX: PHIA), a global leader in health technology, has signed an agreement to […]
Winc’s Initial Public Offering
Latham & Watkins represented Winc, Inc. in the offering. Manatt Represents Spartan Capital Securities LLC and Revere Securities LLC. Winc, Inc., one of the fastest growing at […]
Expensify’s $70.4 Million Initial Public Offering
Latham & Watkins represented Expensify in the offering. Expensify, Inc., a payments superapp that helps individuals and businesses around the world simplify the way they manage money […]
Mojito’s $20 Million Seed Investment
Latham & Watkins advised Mojito in the transaction. Mojito, a new NFT commerce suite, announced it has raised US$20 million in its first funding round with […]
Meta’s Acquisition of Within
Cooley LLP advised Within on the deal. Within, a Los Angeles-based firm responsible for developing immersive virtual reality fitness app Supernatural, announced its agreement to sell to […]
GE Healthcare’s $1.45 Billion Acquisition of BK Medical
Schiff Hardin advised BK Medical on the deal. Latham & Watkins represented Altaris Capital. GE Healthcare has entered into an agreement to acquire BK Medical, a […]
Definitive Healthcare’s $420 Million Initial Public Offering
Latham & Watkins represented the underwriters in the offering. Definitive Healthcare Corp., an industry leader in healthcare commercial intelligence, has announced the pricing of its initial public […]
SentinelOne’s IPO and Concurrent Private Placement
Fenwick & West LLP advised SentinelOne on the deal, while Latham & Watkins LLP represents the underwriters. SentinelOne, an autonomous cybersecurity platform company, announced its initial public […]
eFFECTOR Therapeutics’ Merger with Locust Walk Acquisition Corp.
Latham & Watkins LLP represented eFFECTOR in the transaction, eFFECTOR Therapeutics, Inc. (eFFECTOR), a biopharmaceutical company focused on pioneering the development of selective translation regulation inhibitors […]